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INTRODUCTION
Hepatic encephalopathy may be defined as a disturbance
in central nervous system function because of a hepatic insuf-
ficiency. This broad definition reflects the existence of a spec-
trum of neuropsychiatric manifestations related to a range of
pathophysiological mechanisms. Present in both acute and
chronic liver failure, these neuropsychiatric manifestations
are potentially reversible (1). However, patients who are irri-
table or confused are more difficult to care for and require
greater medical supervision, and patients in deeper stages of
coma are more likely to develop severe complications, such
as aspiration pneumonia (2). 
Acute intestinal pseudo-obstruction is one of the most fatal
conditions in cirrhotic patients (3). Especially, acute hepatic
encephalopathy with acute intestinal pseudo-obstruction may
be a catastrophic condition in cirrhotic patients. Gut-derived
toxins of nitrogenous origin are thought to play a role in the
genesis of acute hepatic encephalopathy. Thus, treatment is
aimed at reducing the production and absorption of these
compounds. Lactulose (orally or as an enema) is one of the cor-
nerstones of the treatment of hepatic encephalopathy (4). And,
bowel cleansing is a mainstay of therapy (1). However, bowel
cleansing and lactulose enemas may be useless in patients with
functional or mechanical bowel obstruction. Furthermore,
oral therapy can be harmful because of a risk of aspiration.
We treated a 49-yr-old man with neostigmine, who had
liver cirrhosis, acute hepatic encephalopathy, and acute intesti-
nal pseudo-obstruction. Initially, we treated him with lactu-
lose enemas. But, there was no improvement in his mental
state. Therefore, with the consent of his family, we gave him
0.5 mg of neostigmine to improve his peristaltic movement.
CASE REPORT
A 49-yr-old man presented to the emergency room with
mental confusion and vomiting in December 2003. Two days
earlier he had abrupt onset of abdominal pain, vomiting, and
constipation. Since then, he had exhibited slurred speech. A
search of his home found no prescription medication. He had
liver cirrhosis with hepatitis B. He had two episodes of hep-
atic encephalopathy since 2002, and had been on oral lactu-
lose therapy. 
His blood pressure was 130/90 mmHg, and pulse rate was
64 beats/min. On physical examination, he was neurologically
in a disoriented and drowsy mental state. His abdomen was
distended, and bowel sound was absent. Ascites were noted.
Laboratory investigations revealed a white blood cell count
of 3,000/ L; hemoglobin 8.1 g/dL; platelet count 22,000/ L;
serum aspartate transaminase 65 U/L; alanine transaminase
32 U/L; albumin 1.9 g/dL; total bilirubin 3.5 mg/dL; ammo-
nia 185  g/dL; blood urea nitrogen 22.3 mg/dL; creatinine
1.2 mg/dL; sodium 143 mEq/L; potassium 4.5 mEq/L; glu-
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Neostigmine for the Treatment of Acute Hepatic Encephalopathy with
Acute Intestinal Pseudo-obstruction in a Cirrhotic Patient
We treated a 49-yr-old man with neostigmine, who had liver cirrhosis, acute hepatic
encephalopathy, and acute intestinal pseudo-obstruction. He was admitted in a state
of hepatic confusion. On physical examination, the abdomen was distended; and
bowel sound was absent. Plain abdomen film revealed multiple air-fluid levels and
distention of bowel loops. Initially, we gave him lactulose enemas every 6 hr for one
day without improvement in his mental state. Furthermore, he became to a state
of coma. Therefore, we gave him 0.5 mg of neostigmine subcutaneously to improve
his peristaltic movement, and 2 L of polyethylene glycol electrolyte solution through
a nasogastric tube for 4 hr to reduce the production and absorption of gut-derived
toxins of nitrogenous compounds. After these treatments, the venous ammonia level
decreased to the normal range within 12 hr, and the coma disappeared after 2 days.
We suggest that neostigmine may be one of the most effective treatments to initiate
peristaltic movement and bowel cleansing in cirrhotic patients with acute hepatic
encephalopathy and acute intestinal pseudo-obstruction. 
Key Words : Hepatic Encephalopathy; Liver Cirrhosis; Intestinal Pseudo-Obstruction; Neostigmine
Received : 6 January 2004
Accepted : 26 February 2004Neostigmine for Hepatic Encephalopathy and Intestinal Pseudo-obstruction 151
cose 110 mg/dL; prothrombin time 25.1 sec (2.2 in interna-
tional normalized ratio); partial thromboplastin time 73.2
sec (vs. a control of 35 sec); alpha-fetoprotein 3.14 ng/mL.
Plain abdomen (upright film) revealed multiple air-fluid
levels, distention of bowel loops, and presence of bowel gas
in the left lower quadrant of the abdomen (Fig. 1). Initially,
we gave him lactulose enemas every 6 hr for one day. Oral
lactulose was not used because of frequent vomiting and ileus.
However, there was no improvement in his mental state. Fur-
thermore, he became to a state of coma, and there was an ele-
vation of his venous ammonia level (298  g/dL). Computed
tomography of the head revealed no evidence of intracranial
hemorrhage or cerebrovascular injury. Therefore, with the
consent of his family, we gave him 0.5 mg of neostigmine
subcutaneously to improve his peristaltic movement. Three
minutes after this treatment, there was a prompt evacuation
of stool with a reduction in abdominal distention and an in-
crease in bowel sound on physical examination. Then we gave
him 2 L of polyethylene glycol electrolyte solution through
a nasogastric tube for 4 hr. After these treatments, his venous
ammonia level decreased to the normal range (19.0-60.0  g/
dL) within 12 hr, and the coma disappeared after 2 days. Plain
abdomen (upright film) also revealed no air-fluid level (Fig. 2).
Then, oral lactulose therapy was restarted, and his condition
remained stable. After 5 days, he was discharged from the
hospital. 
DISCUSSION
We present the first case of acute hepatic encephalopathy
with acute intestinal pseudo-obstruction in a cirrhotic patient
who was successfully treated with neostigmine. Kiba et al. (2)
reported the first successful treatment with neostigmine and
polyethylene glycol electrolyte solution in a cirrhotic patient
with acute hepatic encephalopathy. But, the patient did not
demonstrate the signs of acute intestinal pseudo-obstruction. 
Nitrogenous substances derived from the gut are thought
to play a role in the pathogenesis of hepatic encephalopathy.
These compounds gain access to the systemic circulation as
a result of decreased hepatic function or portal systemic shunts.
Once in brain tissue, they produce alterations of neurotrans-
mission that affect consciousness and behavior (1). Most mani-
festations of hepatic encephalopathy are reversible with med-
ical treatment. However, some patients have progressive debil-
itating syndromes, such as dementia, spastic paraparesis, cere-
bellar degeneration, and extrapyramidal movement disorders,
associated with structural abnormalities of the central nervous
system (2). In addition, it is well known that mortality is
higher with an acute encephalopathy that is classified as Child’s
C and grade III or IV hepatic encephalopathy (5). Therefore,
a treatment regimen that produces a more rapid response is
likely to be of greater benefit to cirrhotic patients, especially
in Child’s C (4). 
Ileus refers to the partial or complete blockage of the small
and/or large intestine either because the regular rhythmic
squeezing motion is impaired or because of mechanical obst-
ruction. Both types, functional or mechanical bowel obstruc-
tion, are associated with increased luminal pressure that might
cause gut wall ischemia and may lead to increase in intra-ab-
dominal pressure. Intra-abdominal hypertension has been
found in up to 20% of critically ill patients and may lead to
Fig. 1. Plain abdomen (upright film) reveals multiple air-fluid levels,
distention of bowel loops, and presence of bowel gas in the left
lower quadrant of the abdomen.
Fig. 2. Two days after the use of neostigmine and polyethylene gly-
col electrolyte solution, plain abdomen (upright film) shows only
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a broad pattern of systemic consequences with multiple organ
dysfunctions, including cardiovascular, hepatic, pulmonary,
renal and neurological function (6). The most serious compli-
cation is the abdominal compartment syndrome, a life-threat-
ening condition presenting as an indication for decompressive
laparotomy. Cirrhosis patients with ascites often have intestinal
pseudo-obstruction (3). Consistent with this, it was reported
that acute intestinal pseudo-obstruction developed after surgery
or severe illness (7-9). However, there was no reported case of
acute intestinal pseudo-obstruction with acute hepatic ence-
phalopathy in cirrhotic patients according to review of English
literature. We suspect that there was little possibility of sur-
vival in cirrhotic patients with acute hepatic encephalopathy
and acute intestinal pseudo-obstruction, because this combined
illness may be a catastrophic condition in cirrhotic patients.
Although the pathophysiology of acute intestinal pseudo-
obstruction is not fully understood, it is thought to result from
an imbalance in the regulation of colonic motor activity by
the autonomic nervous system. Multiple pharmacologic and
metabolic factors can alter the autonomic regulation of colonic
function, leading to excessive parasympathetic suppression,
sympathetic stimulation, or both. This imbalance results in
colonic atony or pseudo-obstruction. Therefore, neostigmine
has been used as a simple, safe, and effective therapy for treat-
ment of intestinal pseudo-obstruction (7-9), because this drug
enhances excitatory parasympathetic activity by competing
with acetylcholine for attachment to acetylcholinesterase at
sites of cholinergic transmission (10). In the present case, there
was no bowel sound before the administration of neostigmine.
However, after the administration of neostigmine, there was
a prompt evacuation of stool with an increase in bowel sound.
Therefore, we thought that neostigmine was a salvage treat-
ment to initiate the peristaltic movement and bowel cleans-
ing so that dietary and endogenous nitrogenous substances
could be evacuated from the intestine. 
The elimination half-life of neostigmine after intravenous
infusion averages 80 min. Neostigmine is hydrolyzed by plas-
ma cholinesterase and is metabolized by microsomal liver
enzymes. Renal excretion accounts for the clearance of 50 per-
cent of the drug, and the serum half-life is prolonged in pati-
ents with renal dysfunction. Therefore, patients with renal
impairment may have an increased or prolonged vagomimetic
response after the administration of neostigmine (8). Con-
traindications for neostigmine are serum creatinine concen-
tration >3 mg/dL, heart rate <60 beats/min, systolic blood
pressure <90 mmHg, active bronchospasm, and signs of bowel
perforation (11). In the present case, we used 0.5 mg of neo-
stigmine because we thought that patients with hepatic dys-
function might have an increased or prolonged vagomimetic
response after the administration of neostigmine. Actually,
there was a prompt bowel response after the administration
of 0.5 mg of neostigmine. Therefore, a second administration
of neostigmine was not used.
In the present case, we used the polyethylene glycol elec-
trolyte solution as a whole gut irrigation solution because of
several reasons. First, we initially used the lactulose enema,
but there was no improvement in his mental state. Therefore,
we could not use it again. Second, there was a necessity of rapid
bowel cleansing, because one day was already passed over
without any improvement of his mental state. Third, colonic
cleansing was reported to be better with polyethylene glycol
electrolyte lavage (12). 
In conclusion, we suggest that neostigmine may be one of
the most effective treatments to initiate peristaltic movement
and bowel cleansing in cirrhotic patients with acute hepatic
encephalopathy and acute intestinal pseudo-obstruction. 
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